HSE National Clinical Guidelines

The NCCP has published two National Clinical Guidelines:

  • Active surveillance for patients with prostate cancer (2025)
  • The Use of Focal Therapy in Patients with Prostate Cancer (2025)

The National Clinical Guidelines are now available on the HSE National Central Repository: 

  1. https://www2.healthservice.hse.ie/organisation/national-pppgs/hse-national-clinical-guideline-active-surveillance-for-patients-with-prostate-cancer/
  2. https://www2.healthservice.hse.ie/organisation/national-pppgs/hse-national-clinical-guideline-the-use-of-focal-therapy-in-patients-with-prostate-cancer/

 cover-page-merge

The purpose of these National Clinical Guidelines is to provide evidence-based recommendations.

The National Clinical Guidelines were developed through the integration of the best research evidence with clinical expertise, patient values and experiences.

The guidelines were developed a multi-disciplinary guideline development group chaired by:

  • Mr David Galvin, Mater Misericordiae University Hospital and St. Vincent’s University Hospital
  • Dr Eve O’Toole, Head of Evidence & Quality in the NCCP
Last updated on: 14 / 04 / 2025